Journal of Pediatric Orthopaedics · 2002 · 58 citations · 11 references
MedicineOrthopaedic SurgerySurgeryNeuromuscular DisordersOrthopedicsPhysical TherapyBotulinum Toxin TherapyBotulinum Toxin TreatmentNeuromuscular OrthopaedicsNeuromuscular OrthopedicsCerebral Palsy OrthopaedicsCerebral Palsy Spasticity SurgeryElectromyographyInterventional Ultrasound GuidanceIntramuscular ElectromyographyIntramuscular StimulationPsoas Muscle AreaUltrasound Guidance
Symptomatic hip flexion deformity secondary to iliopsoas spasticity may interfere with gait, impair sitting balance, or contribute to hip subluxation or dislocation. A nonsurgical, minimally invasive technique to ameliorate iliopsoas spasticity is presented. The technique uses intramuscular injections of botulinum A toxin to provide selective neuromuscular blockade of the iliacus or psoas muscles or both. Because of the anatomic location of the target muscles, this technique uses ultrasound guidance for needle placement. Active electromyographic stimulation is used to verify the needle position adjacent to active myoneural interfaces. The authors' experience to date includes the treatment of 28 patients (53 hips). Use of this technique has resulted in improved hip range of motion. No intraoperative or postoperative adverse events or complications have been observed.
11
Management of Cerebral Palsy with Botulinum-A Toxin
L. Andrew Koman, James F. Mooney, Beth Paterson Smith et al. · Journal of Pediatric Orthopaedics · 1993 · 417 citations
Medicine, Neurology, Pharmacotherapy +14
Intrathecal Baclofen for Spasticity in Cerebral Palsy
A. Leland Albright · JAMA · 1991 · 284 citations
Pharmacy, Neurology, Pharmacotherapy +14